In NPM1/FLT3 co-mutated AML, concurrent menin and FLT3 inhibition dismantles cooperative HOX-dependent fitness while suppressing mitogenic drive, offering a chemo-sparing strategy (Carter et al., 2023). This evidence concerns the gene MEN1 and acute myeloid leukemia.